DOUBLE BUBBLE ORANGE

Hazardous Ingredients

CAS Number EPOXY RESIN KAOLIN 25068-38-6 TRADE SECRET FUMED SILICA TRADE SECRET *** ALL Ingredients in this product are listed in the T.S.C.A. Inventory SECTION III - HAZARDS IDENTIFICATION EYE CONTACT: PRODUCT IS MODERATELY IRRITATING TO THE EYES. SKIN CONTACT: PRODUCT IS MODERATELY IRRITATING TO THE SKIN. MAY CAUSE SKIN SENSITIZATION. SKIN SENSITIZATION MAY BE EVIDENCED BY RASHES, ESPECIALLY HIVES. INHALATION: BECAUSE OF ITS LOW VOLATILITY THIS PRODUCT IS NOT LIKELY TO BE AN INHALATION HAZARD. INGESTION: THIS PRODUCT IS CONSIDERED TO HAVE A LOW ORDER OF ACUTE ORAL TOXICITY. AGGRAVATED MEDICAL CONDITIONS: PREEXISTING SKIN AND EYE DISORDERS MAY BE AGGRAVATED BY EXPOSURE TO THIS PRODUCT. PREEXISTING SKIN OR LUNG ALLERGIES MAY INCREASE THE CHANCE OF DEVELOPING INCREASED ALLERGY SYMPTOMS FROM EXPOSURE TO THIS PRODUCT. HEALTH HAZARD INFORMATION: OTHER HEALTH INFORMATION (EPOXY RESIN): CHRONIC STUDIES: RECENT 2 YEAR BIOASSAYS IN MICE EXPOSED BY THE DERMAL ROUTE TO EPOXY RESIN, THE DIGLYCIDYL ETHER OF BISPHENOL A (DGEBPA), OR TO RESINS PREDOMINANTLY OF DGEBPA HAVE YIELDED VERY LIMITED EVIDENCE OF WEAK CARCINOGENICITY. DGEBPA IS A COMPONENT OF THE RESIN IN THIS PRODUCT. THE AU- THORS OF THIS WORK CONCLUDED THAT THE RENAL TUMOR EVIDENCE WITH THIS RESIN "WAS OF NO BIOLOGICAL SIGNIFICANCE" AND THAT THE RESIN "IS NOT A SYSTEMIC CARCINOGEN WHEN APPLIED TO THE DORSAL SKIN OF CF 1 MICE." IARC CONCLUDED THAT DGEBPA WAS NOT CLASSIFIABLE AS A CARCINOGEN (IARC GROUP 3) BASED ON THE FOL- LOWING: HUMAN AND ANIMAL EVIDENCE BOTH INADEQUATE. MUTAGENICITY: BOTH THE RESIN AND DGEBPA, HAVE PROVED TO BE INACTIVE WHEN TESTED BY IN VIVO MUTAGENICITY ASSAYS. THEY HAVE BOTH SHOWN ACTIVITY BY THE IN VITRO MICROBIAL MUTAGEN- ICITY SCREENING AND HAVE BOTH PRODUCED CHROMOSOMAL ABERRA- TIONS IN CULTURED RAT LIVER CELLS. THE SIGNIFICANCE OF THIS INFORMATION TO MAN IS UNKNOWN.